Clinical Trial Update: Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in multiple sclerosis evaluating an alternate pre-medication strategy for anti-CD20 therapy; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of Miami | Conditions: Multiple Sclerosis | Phase 3 | Status: NOT_YET_RECRUITING